Obesity accelerates age defects in B cells, and weight loss improves B cell function.

Area of Science:

• Immunology
• Metabolic Health
• Aging Research

Background:

• Obesity accelerates age-related immune dysfunction, impairing B cell function and antibody production.
• This leads to reduced protective antibodies and increased autoimmunity, impacting overall health.
• Previous research indicates a link between obesity, aging, and compromised immune responses.

Purpose of the Study:

• To investigate if weight reduction in obese adults improves immune responses, specifically antibody production and autoimmunity.
• To compare immune profiles of obese adults undergoing weight loss to lean adults.
• To evaluate the impact of weight reduction on B cell function and inflammatory markers.

Main Methods:

• Blood samples from lean, elderly, and obese female adults were analyzed before and after a 12-month weight reduction program.
• Participants received the Trivalent Inactivated Influenza vaccine; serum was assessed for cytokines, adipokines, and antibodies.
• B cell populations, RNA expression (transcription factors, inflammatory markers), and cytokine secretion were evaluated using flow cytometry and qPCR.

Main Results:

• Obesity, like aging, increased pro-inflammatory cytokines and autoimmune antibodies while decreasing vaccine-specific antibodies.
• Obese individuals showed B cell enrichment in pro-inflammatory subsets with markers of senescence and altered transcription factor levels (higher T-bet, lower E47).
• Weight loss significantly reduced these pro-inflammatory B cell characteristics, but did not fully restore normal function.

Conclusions:

• Obesity-induced B cell dysfunction, similar to aging, can be partially ameliorated by weight loss in some individuals.
• Weight reduction positively impacts mechanistic pathways related to immune function in obese adults.
• Further research is needed to fully understand the long-term effects and mechanisms of weight loss on immune responses.